telmisartan has been researched along with natriuretic peptide, brain in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, C | 1 |
| Adachi, M; Anraku, M; Kitamura, K; Miyoshi, T; Nonoguchi, H; Shimada, H; Tanaka, M; Tomita, K; Tuyen, DG; Wakamatsu, S | 1 |
| Ioannidis, G; Katritsis, D; Koulouris, S; Symeonides, P; Thalassinos, N; Triantafyllou, K; Vratsista, E | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Haraguchi, G; Isobe, M; Kosuge, H; Maejima, Y; Okada, H; Onai, Y; Suzuki, J | 1 |
| Jinnouchi, H; Kataoka, K; Kim-Mitsuyama, S; Matsui, K; Node, K; Ogawa, H; Sekigami, T; Soejima, H; Yamamoto, E; Yamamuro, M; Yasuda, O | 1 |
| Aoki, H; Hoshide, S; Kario, K; Matsumoto, Y; Mizuno, H; Noshiro, T; Okazaki, O; Uchiyama, K; Yoshida, T | 1 |
| Lan, Y; Li, X; Lu, Y; Nie, M; Wang, Y; Zhao, E | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM | 1 |
| Cai, Y; Chang, D; Ju, S; Lu, CQ; Min, SD; Wang, YC; Xu, TT; Zhang, SJ; Zhao, Z | 1 |
6 trial(s) available for telmisartan and natriuretic peptide, brain
| Article | Year |
|---|---|
Rationale and design of the cardiac magnetic resonance imaging substudy of The ONTARGET Trial Programme.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Ramipril; Research Design; Telmisartan; Time Factors | 2005 |
Effect of telmisartan on ambulatory blood pressure monitoring, plasma brain natriuretic peptide, and oxidative status of serum albumin in hemodialysis patients.
Topics: Aged; Aldosterone; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Oxidation-Reduction; Renal Dialysis; Renin; Serum Albumin; Telmisartan | 2005 |
Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Flow Velocity; Cardiomyopathies; Cross-Over Studies; Diabetes Complications; Double-Blind Method; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Statistics, Nonparametric; Telmisartan; Treatment Outcome | 2007 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2016 |
Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Drug Combinations; Female; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Prospective Studies; Telmisartan; Treatment Outcome | 2016 |
4 other study(ies) available for telmisartan and natriuretic peptide, brain
| Article | Year |
|---|---|
Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Connective Tissue Growth Factor; Echocardiography; Enzyme Activation; Macrophages; Male; Metalloproteases; Myocardial Infarction; Natriuretic Peptide, Brain; Osteopontin; PPAR gamma; Rats; Rats, Sprague-Dawley; Survival Analysis; Telmisartan; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Ventricular Remodeling | 2011 |
Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Cardiomegaly; Cell Nucleus; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Signal Transduction; Telmisartan | 2017 |
Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclic AMP-Dependent Protein Kinases; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Telmisartan | 2019 |
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardio-Renal Syndrome; Diastole; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Stroke Volume; Telmisartan; Ventricular Function, Left; Ventricular Remodeling | 2021 |